SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-16-111085
Filing Date
2016-07-01
Accepted
2016-07-01 12:25:02
Documents
5
Effectiveness Date
2016-07-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A v443251_defa14a.htm DEFA14A 12144
2 GRAPHIC page_1.jpg GRAPHIC 62042
3 GRAPHIC page_2.jpg GRAPHIC 98614
4 GRAPHIC page_3.jpg GRAPHIC 28011
5 GRAPHIC page_4.jpg GRAPHIC 12146
  Complete submission text file 0001144204-16-111085.txt   290271
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35076 | Film No.: 161745689
SIC: 2835 In Vitro & In Vivo Diagnostic Substances